(Total Views: 48)
Posted On: 04/01/2019 8:50:28 AM
Post# of 43071

BOSTON, MASSACHUSETTS, March 18, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), a developmental stage biotechnology company, with a pipeline of anti-necrosis drugs designed to treat hypoxia by delivering a small molecule carrying oxygen to the brain of stroke victims, announced today that the Company has retained Resources Unlimited NW, LLC., a strategic investor relations agency, with a wealth of experience in biotech to manage the company’s investor relations program.


Scroll down for more posts ▼